Open-label Study of the Efficacy and Safety of VESIcare® in Patients With Overactive Bladder Symptoms

Clinical trial NCT00463541 · COMPLETED

Trial details

NCT number: NCT00463541
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urinary Bladder, Overactive

Start date: 2004-06-01
Primary completion: 2005-04-01
Enrollment: 2225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.